Aksnes TA - Search Results

1

Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT-1 receptor blockade.

Aksnes TA, Flaa A, Sevre K, Mundal HH, Rostrup M, Kjeldsen SE. Aksnes TA, et al. Blood Press. 2008;17(3):156-63. doi: 10.1080/08037050802162847. Blood Press. 2008. PMID: 18608197 Free article. Clinical Trial.

2

Hypertension and atrial fi brillation with emphasis on prevention.

Aksnes TA, Kjeldsen SE, Schmieder RE. Aksnes TA, et al. Blood Press. 2009;18(3):94-8. doi: 10.1080/08037050903040744. Blood Press. 2009. PMID: 20499443 Free article. Review. No abstract available.

3

Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.

Aksnes TA, Kjeldsen SE, Rostrup M, Holzhauer B, Hua TA, Julius S. Aksnes TA, et al. Blood Press. 2016 Aug;25(4):235-40. doi: 10.3109/08037051.2015.1134071. Epub 2016 Jan 25. Blood Press. 2016. PMID: 26808585 Free article. Clinical Trial.

4

Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.

Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE. Aksnes TA, et al. J Hum Hypertens. 2006 Nov;20(11):860-6. doi: 10.1038/sj.jhh.1002087. Epub 2006 Sep 21. J Hum Hypertens. 2006. PMID: 16988754 Clinical Trial.

5

Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity.

Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE. Aksnes TA, et al. Metabolism. 2007 Nov;56(11):1470-7. doi: 10.1016/j.metabol.2007.06.012. Metabolism. 2007. PMID: 17950096 Clinical Trial.

6

High screening blood pressure at young age predicts future masked hypertension: A 17 year follow-up study.

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA. Skårn SN, et al. Among authors: aksnes ta. Blood Press. 2015 Jun;24(3):131-8. doi: 10.3109/21695717.2015.1030889. Epub 2015 Apr 22. Blood Press. 2015. PMID: 25901999 Free article.

7

Prevention of atrial fibrillation in hypertension.

Aksnes TA, Flaa A, Strand A, Kjeldsen SE. Aksnes TA, et al. Curr Hypertens Rep. 2008 Jun;10(3):175-81. doi: 10.1007/s11906-008-0034-x. Curr Hypertens Rep. 2008. PMID: 18765086 Review.

8

Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.

Aksnes TA, Flaa A, Strand A, Kjeldsen SE. Aksnes TA, et al. J Hypertens. 2007 Jan;25(1):15-23. doi: 10.1097/01.hjh.0000254378.26607.1f. J Hypertens. 2007. PMID: 17143167 Review.

9

Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population.

Aksnes TA, Kjeldsen SE, Rostrup M, Omvik P, Hua TA, Julius S. Aksnes TA, et al. Hypertension. 2007 Sep;50(3):467-73. doi: 10.1161/HYPERTENSIONAHA.106.085654. Epub 2007 Aug 6. Hypertension. 2007. PMID: 17679652 Clinical Trial.

10

Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study.

Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Flaa A, et al. Among authors: aksnes ta. Metabolism. 2008 Oct;57(10):1422-7. doi: 10.1016/j.metabol.2008.05.012. Metabolism. 2008. PMID: 18803948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters